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1. Introduction 
Specific receptors for angiotensin II (A II) have 
been shown in glomeruli isolated from rat kidney cor- 
tex and related to glomerular vase-reactivity [l]. The 
localization of A II receptors within the glomerulus 
and the relationship between these receptors and the 
physiological functions of the corresponding cells are 
still unknown. After injection of tritiated A II into 
the renal artery of the rat, 3H radioactivity was 
observed by autoradiography in the mesangial cells 
[2], but the physiological significance of this uptake 
remained imprecise. High affinity binding sites for A 
II on rat glomerular basement membranes were 
observed [3] but no experimental data allowing cor- 
relation of this binding with a physiological function 
was provided. Homogeneous populations of glomeru- 
lar epithelial and mesangial cells have now been cul- 
tured [4,5]. It is thus possible to study the biochem- 
ical properties of these two different glomerular cell 
populations. We have shown that the mesangial 
cells represent the main site of prostaglandin (PC) E2 
glomerular synthesis [6]_ Here, we provide evidence 
for localization of specific A II receptors on the 
mesangial cells and emonstrate hat the binding of 
A II to these receptors induces a contractile response 
of mesangial cells. 
2. Experimental 
2.1. Materials 
(Asn’, Val’) A II was donated by Ciba-Geigy (Basel) 
and labeled with *“I by the method in [7]. Labeled 
and unlabeled molecules were separated by using 
polyac~lamide gel electrophoresis according to [8]. 
The specific activity of the labeled hormone assessed 
Efsev&?r/North-Holland Biomedical Press 
by radio~unoassay was 2000 Cilmmol. This is 
close to the theoretical value corresponding to 1 iodine 
atom~molecule. The following peptides were pur- 
chased from the commercial sources as indicated: 
(Sar’, Ala8) A II, (Sar’, Ile8) A II, (Des Asp’, Be’) A 
II and 1-34 bovine PTH from Beckman (Geneva); 
lysine-vasopressin from Sandoz (Basel); l-24 ACTH 
fragment from Ciba-Geigy. One synthetic analogue of 
A II (Des Asn’, Val’) A II was kindly provided by 
Professor Riniker (Ciba-Geigy). 
2.2. Cett cuttures 
Renal glomeruli were isolated from Spra~e-Dawley 
rats (150-220 g) as in [4]. The final preparation con- 
tained purified glomeruli without Bowman’s capsules 
and afferent or efferent arteries. These glomeruli were 
cultured at 37’C in plastic flasks containing 5ml 
RPM1 medium (Flow Labs., Irvine), supplemented 
with 10% decomplemented fetal bovine serum, and 
buffered with 20 mM N-2-hydroxyethylpiperazine- 
N’-2-ethanesulphonic acid (Hepes, pH 7.2). Epithelial 
cells grow rapidly with a peak of cell division on day 
6 whereas mesangial cells grow at a slower rate with a 
maximum of cell division on day 22. These 2 cell 
populations were therefore separated by subculture 
at these 2 different times. The conditions of the sub- 
cultures were identical to those used for isolated 
glomeruli. Culture media were changed every 2 days. 
For the binding experiments, the epithelial and the 
mesangial celIs were tested 5 and 15 days, respectively, 
after initiation of the subculture. These dates corre- 
spond to the maximum recovery by these cells of 
their biological properties [4,6,9]. 
2.3. Binding expehen ts 
Binding experiments were done using dissociated 
cells scraped off their flasks. This technique allows 
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precise replication of the binding studies, since uni- 
form aliquots of the starting cell suspension are used. 
Flasks containing mesangial or epithelial cells were 
washed with 5 ml of Dulbecco’s olution (137 mM 
NaCl, 2.6 mM KCl, 8 mM NasHPOe, 1.5 mM KHsPOa, 
5 6 mM glucose, pH 7 2) and then exposed to 5 ml of 
this same solution containing 0.5 mM EDTA (disodi~ 
salt) for 3 min at 22°C. This medium was removed 
and replaced by 5 ml Dulbecco’s olution containing 
380 III/ml type I collagenase and 1 mglml soybean 
trypsin inhibitor (Sigma, St Louis MO). Incubation 
with the latter medium was performed at 37OC for 
10 min. The supernatant was aspirated and kept. 
Hank’s balanced salt solution (pH 7.2) (no. 19-101-54, 
Flow Labs.) S ml, containing 2mM CaCl? and 2 mM 
MgCls (buffer A) were then added to the flask and 
the cells were scraped away using a rubber policeman. 
The suspension obtained an the supernat~t collected 
after collagenase treatment were filtered through a 50 
/,nn sieve. The filtrate was then centrifuged at 120 X g 
for 10 min and the supernatant discarded. The pellet 
was washed once again in the same conditions after 
addition of 5 mlbuffer A. Binding studies were then 
done under 100 @l buffer A supplemented with 2 g/ 
100 ml bovine serum albumin (Sigma) pre-heated 
at 56°C for 30 min and 125 pg/ml of l-24 ACTH 
fragment. As shown in[l], the latter product inhibits 
degradation of the tracer without affecting binding 
kinetics. ‘251-iabeled A II (“‘1-A II) was added at 0.5 
nM and incubated with 20-40 @g cellular protein/ 
tube at 20-22’C for 40 min. At the end of the incu- 
bation, bound radioactivity was separated using Bltra- 
tion through a Millipore filter (0.22 m GS). ‘*‘I was 
counted with a crystal type scintillation detector 
giving 63% efficiency. An aliquot of the cell suspen- 
sion was also used for protein determination [lo]. 
Specific binding was calculated by subtracting the 
binding in the presence of 5 /.LM unlabeled A II from 
total binding and expressed as fmol bound hormone/ 
mg cellular protein. To verify that the drugs used to 
dissociate the cells (disodium EDTA and collagenase) 
did not degrade the receptors for A II, isolated 
glomeruli were treated similarly to the cells. Binding 
studies were performed in parallel using control and 
treated isolated glomeruli. No inhibition of binding 
was observed but, on the contrary, a slightly greater 
amount of 12’I-A II bound to the treated glomeruli. 
2.4. Degradation studies 
Degradation of lzsI.A II present in the incubation 
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medium was studied using either the binding to an 
excess of specific antibodies or the rebinding to 
freshly isolated glomeruli [11. Binding of i2’I-A II to 
an excess of specific antibody was measured after 16 
h incubation. This antibody had been raised in a rab- 
bit and was used at a final dilution of l/400, at which 
>90% of the total radioactivity was bound. It could 
not distinguish between A II and (Des Asp’, Be’) A II 
but only slightly crossreacted with the smaller frag- 
ments of the hormone. Free and bound radioactivities 
were separated by using Dextran-coated charcoal. 
Rebinding of 125I-A II to freshly isolated glomeruli 
was measured after 40 min incubation in the same 
conditions as those used for the cells. In each experi- 
ment, appropriate controls were prepared which were 
identical except hat cells were omitted. These con- 
trols represented 100% of the hormone available for 
degradation. To evaluate hormone degradation, results 
were expressed as % of control activity remaining 
after the same incubation period. 
2.5. Evaluation of cellular reactiviv 
Reactivity of cultured epithelial or mesangial cells 
to A II was first studied by phase contrast microscopy 
as in [9]. In short, the cultured cells were lirst 
incubated at 37°C for 1 h with 5 ml buffer A. A II 
was then added at 10 pM-50 nM. The changes in 
length, shape or phase lucency were observed within 
15 min after introduction of the agonist. Cultured 
cells incubated in the presence of buffer A without 
subsequent addition of A II were used as controls. 
The myosin distribution in contracting mesangial 
cells is quite different from that observed in non-con- 
tracting mesangial cells, as shown by indirect immuno- 
fluorescence u&g a specific ~timyo~n antiart 
141. Indeed no prominent fibrillar structures could be 
detected in the cytoplasm of the contracting mesangial 
cells (frg.1). Therefore, the cellular eactivity was also 
studied by indirect immunofluorescence. Mesangial 
cells were grown to confluency on glass cover slips in 
the same culture medium as that used in the plastic 
flasks. Cover slips with cell monolayer were washed 3 
times with buffer A (15 min each time). The cells 
were then incubated for 15 min at 37’C with this 
same buffer containing A II at 10 pM--50 nM. At the 
end of the incubation, cell preparations were fixed 
for 5 min in absolute methanol at 4°C and washed 3 
times with buffer A (5 min each time), The cells were 
then exposed for 30 min to an antiserum directed 
against myosin and stained using an indirect immuno- 
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F&l. Cultured mesangial cells stained by indirect immunofluorescence using an anti-myosin antiserum, after incubation with 
1 nM angiotensin II. Note the presence of intracelhtlar fibrilhu structures in one (non-contracting) cell and their absence in the 
other (~n~act~g). This Latter celI also exhrbits membr~ous evaghrations. 
fluorescent technique. The cover slips were washed 3 
times with phosphate-buffered saline during 3 ruin 
each time and mounted in 50% glycerin [4]. The cells 
were examined under fluorescence microscopy using 
a Leitz microscope quipped with an II30 SO mer- 
cury lamp. About 500 cells were counted for each 
[A II] tested. Each experiment was performed in 
duplicate. Control mesangial cells incubated without 
A II were examined in parallel, 
3. Results and discussion 
3.1. Binding studies 
“‘1-A II binding was measured as a function of 
time using both epithelial and mesangial cells. Specific 
binding to epithelial cells was very low as compared 
with that obtained with mesangial cells. Therefore 
mesangial cells only were considered in the subse- 
quent studies. The amount of bound i25I-A II increased 
progressively with time and reached asteady state 
after 40 min incubation (fig.2). This experiment was 
Fig.2. Binding of *2sIangiotensin II (0.5 nM) to mesangial 
cells as a function of time: (e) total binding; (0) non-specific 
binding. Each point is the mean of triphcates and each vertical 
bar twice the SEM. 
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repeated at different [l%A II] to calculate the 
kinetic parameters of binding, The following equation 
was used: 
loge RH,4/(RH, - RI-I) = (k+r k + kl)t 
where: RH = bound hormone at any time; RHW = 
bound hormone at equilibrium; h = hormonal concen- 
tration in the incubation milieu. If br and bz are the 
slopes of two association curves tudied at two dif- 
ferent ‘*%A II concentrations (hi and h2, respec- 
tively), the two following equations can be written: 
bl = k+l hl t AT+ and b2 = k+l h2 + k-,, from which 
k+l and km1 can be calculated. The values observed 
were k+ = 0.043 min-r, k+l = 0.00246 X 10” M-" . 
min-’ and Kd = k_llk,l = 1.77 nM. Kinetic param- 
eters could not be calculated from comparison 
between association and dissociation curves because, 
as in [ 1 I], the dissociation of the hormone-receptor 
complex did not obey first-order kinetics when Ca*+ 
and Mg*+ were present in the incubation medium. 
r*‘I-A II specific binding was linearly related to the 
amount of celh$ar protein over 100-400 pgjrnl 
(fig.3). This allowed the results to be expressed as 
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Fig.3. Binding of lWangiotensin II as a function of the con- 
centration of glomerular protein. Each point is the mean of 
duplicates and each vertical bar the difference between them: 
(e) total binding;(o) non-specific binding. Specific binding, 
obtained by subtracting the open from the closed circles, is 
given in the inset. 
Fig.4. Competitive inhibition of binding of ‘aSlangiotensin II
to glomerular mesangial cells in the presence of increasing 
doses of unlabeled angiotenshr II. Each point is the mean of 
duplicates and each vertical bar the difference between them. 
( ---) The concentration corresponding to SO% of binding 
obtained without unlabeled hormone. The Scatchard transfor- 
mation of the data obtained at 10-‘“-10-8 M is given in the 
inset. 
fmol A II bound~mg cellular protein. Dilution of 
‘*‘I-A II (0.5 r&l) with increasing unlabeled [A II] 
from 1 pM-1 @l decreased the amount of labeled 
hormone bound to mesangial dissociated c lls (fig.4). 
Residual binding >o . 1@I corresponded to non-spe- 
cific binding and was <lo% of maximum binding. 
The data in fig.4 were transformed according to 
Scatchard. A linear curve was obtained (fig.4, inset) 
corresponding to 1 group of receptor sites. The 
abscissa intercept allowed calculation of the no. sites 
(43.5 fmol/mg) and the slope, of the Kd value (2.8 
nM). This latter value is close to that derived from 
the time-course studies (1.8 r&I). The ~ibitory 
potency of binding of various A II analogues was also 
studied. The results are shown on table 1. All the A II 
analogues tested at 1 FM strongly inhibited 12sI-A II 
binding. The effect of Sar’, Ala* A II was identical to
that of Asn’, Val’ A II. The other drugs were less 
potent. Unrelated peptides uch as lysine vasopressin 
and the l-34 fragment of bovine parathyroid hor- 
mone were entirely inactive. 
These studies demonstrate hat the binding sites 
for A II present in mesangial cultured cells possess 
most of the characteristics of hormonal receptors: 
(i) Very low calculated &, -1 nM, V&R? similar t0 
those measured for A II-receptor association i  
rat liver 1121, adrenal cortex [13,14] and brain 
membranes [IS]; 
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Table 1 
Competitive inhibition of binding of *~*Iangiotensin II to 
cultured mesa&al cells 
Drugs 
(1 CLM) 
None 
Asn’, Val’ A II 
Des Asu’, Va15 A II 
Des Asp’, He5 A II 
Sar’, Ala* A II 
Sar’, Be* A II 
1-34 bovine PTII 
Lysiuevasopressin 
‘zSI-Angiotensin II Percentage 
bound (fmol/mg) of binding 
5.04 f 0.4Sa 100 
1.08 + 0.23 21.4 f 4.6 
1.52 30.1 
1.87 37.1 
1.03 20.4 
1.59 31.6 
5.07 100.5 
4.97 98.7 
a The two fist results were calculated from 6 individuai values 
and are given as means + SEM 
The other results are means from duplicates 
(ii) Specific inhibition of binding of labeled A II by 
unlabeled hormone and by analogs and antagonists; 
(iii) Binding equilibrium with time. 
In [ 161, we provided evidence for the presence of 
several groups of specific receptor sites for A II in 
glomeruli isolated from rat kidney cortex, and inter- 
preted this finding as resulting from heterogeneity 
of the glomerulus and/or the multiplicity of A II 
effects on the glomerular function. Subsequently [3] 
we could localize some of these receptor sites on the 
glomerular basement membrane. This report indicates 
that another group of sites is present on the mesa&al 
cells, i25I-A II binding to mesangial cells was studied 
in the presence of Ca*’ and Mg2+ in the incubation 
medium at concentrations close to those present in 
the extracellular fluids, since it had been demonstrated 
that specific binding to isolated glomeruli was 
increased in this condition [l I]. In agreement with 
these findings, the effects of A II on the parameters 
of glomerular filtration rate were reversed [ 173 when 
the rats were treated with verapamil, an inhibitor of 
calcium transport hrough the cell membranes. The 
concentration of A II receptor sites’appears to be 
clearly smaller in cultured mesangial cells than in 
isolated whole glomeruli incubated in similar condi- 
tions [ 111. This could reflect either a loss of receptors 
during cultures or binding to only a subpopulation of
cultured cells. 
3.2. Degradation studies 
Degradation of “‘1-A II in the presence of disso- 
ciated mesangial cells was measured with the tech- 
Table 2 
Degradation of ‘251-angiotensin II present in the incubation 
medium 
Incubation Binding to an excess 
(mm) of antibodya 
10 4.5% 
20 4.5% 
50 11% 
a Each point is the mean of duplicates 
Rebinding to fresh 
glomerulia 
13.5% 
26.5% 
24.4% 
niques of rebinding to fresh glomeruli and binding to 
an excess of specific antibodies (table 2). The first of 
these techniques gave % values of degraded hormone 
greater than the second one. Anyway the amount of 
degraded hormone was G!5% after 50 min incuba- 
tion. These results are similar to those observed with 
isolated glomeruli [1,3,11,16]. 
3 -3. Cell reactivity studies 
After incubation in the Hank’s balanced salt solu- 
tion cont~n~g 2 mM CaZi and 2 mM Mg2+, the 
mesangial cells were frequently surrounded by a pro- 
minent contrast halo due to a greater etractility and 
presented either elongated, fusiform or spherical 
shapes [9]. After incubation with A II, changes in 
length or shape of the mesangial cells were observed 
within a few minutes and progressed until -1.5 min 
after addition of this hormone [9]. Similarly, the 
myosin distribution in the contracting mesangial cells 
was quite different from that observed in the non- 
contracting ones (fig.1). The percentage of contractife 
cells increased progressively with the concentration of 
A II added and reached asteady value >lO nM, A 
sigmoidal effect vslog,, dose-curve (was obtained 
fig.5). The calculated E& ([A II] corresponding to
50% of the maximum effect) was 0.74 nM. This value 
is close to the Kd values obtained from time-course 
studies or competitive inhibition studies (fig.4). This 
suggests a specitk relationship between binding sites 
for A II and mesangial cell contractility. Other argu- 
ments in favor of this conclusion are the parallel 
stimulatory effect of Ca2+ and the parallel inhibitory 
effects of (Sar’, Ala*) A II on “‘1-A II binding [l 1] 
and cell reactivity [9]. A rnax~~ of 32% was 
reached for the % of contractile cells. Here, we could 
not determine whether or not 12’I-A II binds only to 
those cells which contract. An affirmative answer is 
suggested by the low concentration of A II receptor 
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Fig.5. Percentage of contractile mesangial cells after 1s mm incubation with unlabeled angiotensin II plotted against [angiotensin II 1. 
Each point represents the mean of 3 determ~ations and each vertical bar twice the SEM. For each determ~ation, -500 mesangial 
cells were counted. (---) The concentration (ED,,) corresponding to SO% of the maximum effect. 
sites compared with that observed with whole glo- 
meruli. Contraction of mesangial cells in the presence 
of 1 nM A II was also observed in [S] but similar 
behavior for all the cells examined was reported. This 
discrepancy isprobably related to the fact that 
cloned mesangial cells were used in [S] but not in 
ours. Cloned cells which derive from the same single 
cell exhibit identical biological properties when they 
are tested. In [S] arginine vasopressin at0.1 nM also 
stimulated mesanglal cell contractility and 3H-labeled 
fysine vasopressin specifically bound to the glomerular 
mesangial cells with an app. Kd of 10 nM. The bind- 
ing studies were, however, limited to time-course 
experiments. 
4. Conclusion 
These findings clearly indicate the presence of 
specitic receptors for A II in mesangial cultured cells 
of glomerular origin and suggest that binding to these 
receptors may be the fust step of the effect of A II 
on glomerular vasoreactivity hrough contraction of 
the mesangial cells. Specific receptors for A II were 
probably also present in epithelial cells but at a much 
lower concentration. One may therefore consider that 
the high affinity binding sites for A II represent a bio- 
chemical marker of the mesangial cells. Fur~ermore, 
since the mesangial cells bind A II, contract in the 
presence of A II, and produce large amounts of PGEa 
[6] it seems reasonable to suggest that these cells, and 
not the epithelial cells, play a major ole in the con- 
trol of glomerular vasoreactivity. It is also possible 
that A II binding sites are related to PG production. 
However, the stim~ation of PG synthesis by the 
mesangial cells in the presence of A II is only clear at 
-10 nM [ 181 which are higher than those required 
for specific binding here. 
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